Gemma Gunn

Gemma Gunn has a robust background in the pharmaceutical industry, beginning as an Analyst at CIL from 2008 to 2009. Subsequently, Gemma held multiple senior leadership roles at AstraZeneca from October 2021 to October 2023, including Global Commercial Head for GYN cancers, Global Business Insights & Analytics Senior Director for Immuno-oncology, and Global Head of Commercialisation for GYN/GU & Early DDR Assets. Prior to AstraZeneca, Gemma served as an Engagement Manager at IMS Consulting Group from January 2009 to February 2017. Gemma earned a PhD in Immunology and Microbiology from the University of Cambridge, where education was completed between 2000 and 2008.